Reports

Survival of mice receiving melanoma transplants is promoted by hydroquinone

Science  25 Apr 1980:
Vol. 208, Issue 4442, pp. 408-410
DOI: 10.1126/science.7367868

Abstract

In BALB/c female mice with melanoma transplants, the incidence of "takes" is decreased and survival is increased by hydroquinone, a melanocytolytic agent. The mechanism of drug action is suggested by via DNA. The significant and high degree of positive response to hydroquinone treatment in vivo is encouraging for the clinical management of melanoma with melanocytolytic agents.

Related Content